Get an email when this journal's indexing changes
Added to or removed from Scopus, Web of Science, ABDC, DOAJ, FT50, UT Dallas or ONOS. One confirmation click; unsubscribe anytime.
Biotechnology and Bioengineering is Scopus-indexed (Q1, CiteScore 7.8), WoS SCIE. It is covered by India's One Nation One Subscription scheme for reading access. Published by Wiley-VCH Verlag.
Checked against the index lists dated .
ISSN 0006-3592Verify ISSN ↗1097-0290Verify ISSN ↗
Publisher: Wiley-VCH Verlag
Cost to publish: About US$5,060 to publish open access (publisher list price, via OpenAlex) — subscription publishing may be free
| Subject area | Rank | Pctile | Q |
|---|---|---|---|
| Applied Microbiology and Biotechnology | 31 / 134 | 77th | Q1 |
| Biotechnology | 91 / 325 | 72nd | Q2 |
| Bioengineering | 53 / 168 | 68th | Q2 |
Not listed in: DOAJ, ABDC, ABS / AJG, FT50, UT Dallas, ONOS (APC covered)
Yes — actively indexed in Scopus, coverage 1962–present, best quartile Q1, CiteScore 7.8.
Biotechnology and Bioengineering is Q1 in Applied Microbiology and Biotechnology (rank 31 of 134), Q2 in Biotechnology (rank 91 of 325) and Q2 in Bioengineering (rank 53 of 168), by CiteScore 2025.
Biotechnology and Bioengineering is indexed in the Science Citation Index Expanded, so it may have a Journal Impact Factor in Clarivate's Journal Citation Reports. JCR is paid, so check it for the current value. The closest free measure is its Scopus CiteScore 7.8, which places it in quartile Q1 at the 77th percentile of its subject. Its SCImago Journal Rank (SJR, a free Scopus-based metric) is 0.877, quartile Q1, with an H-index of 225.
The publisher lists an article processing charge of about US$5,060 for open access (source: OpenAlex). Many journals also publish by the subscription route at no cost to the author, so confirm on the journal's own website.
Biotechnology and Bioengineering is published by Wiley-VCH Verlag. Its print ISSN is 0006-3592 and its online ISSN is 1097-0290.
Yes. It is part of the One Nation One Subscription (ONOS) national subscription, so readers at participating Indian institutions get its full text. ONOS does not cover its article processing charge.
Yes — indexed in the Science Citation Index Expanded.
No — it is not registered as an open-access journal in DOAJ or Scopus.
Biotechnology and Bioengineering has an h-index of 271 and a 2-year mean of 3.73 citations per paper (OpenAlex). Its Scopus CiteScore is 7.8, quartile Q1. On 2-year citations it ranks #49 of 130 Scopus journals in Applied Microbiology and Biotechnology.
Biotechnology and Bioengineering published 293 papers in 2025; its busiest recent year was 2017 with 431. 2026* is the year so far.
h-index, i10-index and 2-year mean citedness are open, licence-clear metrics from OpenAlex — not a proprietary impact factor. The subject rank counts only journals that OpenAlex has a figure for; it is not a Scopus or Clarivate ranking. Updated 2026-10-14.
In its latest 95 research articles (2026), authors are most often from China (20%), United States (13.5%) and India (12%).
Countries are counted fractionally, so a paper by authors from two countries counts half to each.
Scopus status: Active. 9 retracted papers are recorded (0.5 per 1,000 papers). The Problematic Paper Screener flags 2 of its papers. These are indicators to check, not findings against the journal.
Retractions from OpenAlex; flags from the Problematic Paper Screener (Cabanac, Labbé & Magazinov, CC BY), 2026-09-21 export. A flag marks a paper for a closer look; it is not a finding against the journal.
Index data is curated from public sources (Scopus, Web of Science, ABDC, FT50, UT Dallas, DOAJ). CiteScore and quartiles reflect the latest available Scopus release. Always verify a journal's current status on its official source before submitting.
Comments load as you scroll here.